Intralesional methotrexate injection in alopecia areata
Phase 3
- Conditions
- Alopecia Areata.
- Registration Number
- IRCT20141209020250N6
- Lead Sponsor
- Vice chancellor of Research and Technology,Tehran University of Medical Sciences and Health Services
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Adult patients (aged 16-60 years)
Patients with alopecia areata who have less than 20% involvement of the scalp
have not received any treatment for AA in the past 1 month.
Exclusion Criteria
Children and patients under 16 years, pregnant and lactating women, chronic patients including patients with liver or blood disorders, patients with immunodeficiency, infectious disease
patients with diffuse types (alopecia totalis, alopecia universalis and more than 20%) and positive pull tests that are candidates for systemic treatment
patients who were treated for alopecia areata during the previous month
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Alopecia Areata severity index. Timepoint: The beginning of the study, one month, two months, three months, six months after the start of the study. Method of measurement: Viewing Dermoscopy criteria.
- Secondary Outcome Measures
Name Time Method